Ibogaine for Addiction Treatment

A single treatment that eliminates acute withdrawal in 80-90% of patients, with 50-65% maintaining abstinence at 12 months

Medically reviewed: March 2026By: Dr. Sarah Chen, MD, ABAM(Addiction Medicine)10 peer-reviewed sources citedEditorial policy

Why Traditional Treatment Often Fails

Conventional addiction treatment faces a harsh reality: relapse rates exceed 80% within the first year. The reasons are clear:

  • Withdrawal is brutal: Physical symptoms can last weeks; psychological cravings persist for months or years
  • Substitution therapy dependency: Methadone and Suboxone replace one opioid with another, requiring years of daily dosing
  • Slow neurological recovery: Brain receptor damage takes months to heal naturally
  • Root causes unaddressed: Underlying trauma and emotional pain remain untouched
  • Treatment accessibility: Waitlists, stigma, and cost create massive barriers

The Opioid Crisis

Over 100,000 Americans die annually from opioid overdoses. Fentanyl contamination makes every use potentially lethal. We need better solutions.

How Ibogaine Transforms Addiction Treatment

Immediate Withdrawal Elimination

Within 4-6 hours of administration, ibogaine eliminates 90-100% of opioid withdrawal symptoms. Patients report:

  • No nausea, vomiting, or gastrointestinal distress
  • Elimination of muscle aches and restless legs
  • Normal sleep patterns restored
  • No cold sweats or temperature dysregulation
  • Psychological stability instead of panic and anxiety

Receptor Reset and Healing

Ibogaine doesn't just mask symptoms — it repairs the underlying damage:

  • NMDA receptor antagonism: Resets tolerance and breaks physical dependence
  • Dopamine system restoration: Repairs the brain's reward circuitry damaged by chronic drug use
  • GDNF production: Stimulates neuronal repair and growth
  • Serotonin modulation: Stabilizes mood and emotional regulation

Psychological Insight and Trauma Processing

Unlike pharmacological treatments, ibogaine induces a profound introspective experience where patients:

  • Revisit and process traumatic memories driving addiction
  • Gain clarity on behavioral patterns and self-destructive cycles
  • Experience emotional release and acceptance
  • Develop renewed motivation and purpose
  • Confront the root psychological causes of substance use

Extended Craving Reduction

Ibogaine's active metabolite, noribogaine, remains in the system for weeks, providing sustained protection against cravings during the critical early recovery period.

Success Rates by Substance

Opioids (Heroin, Fentanyl, Oxycodone, Morphine)

50-65%Abstinence at 12 months (Noller et al., 2018)

Ibogaine is most effective for opioid addiction. Peer-reviewed studies consistently show:

  • 80-90% experience elimination of acute withdrawal symptoms within 24-48 hours
  • Significant craving reduction in 80-90% of patients
  • 50-65% maintain abstinence at 12 months with proper aftercare (Noller et al., 2018)
  • Effective for fentanyl, heroin, prescription opioids, and methadone/Suboxone tapering

Alcohol

50-70%Success rate at 12 months

Ibogaine shows promise for alcohol dependence:

  • Reduced cravings and compulsive drinking patterns
  • Addresses underlying trauma and emotional triggers
  • May require medical detox before ibogaine due to seizure risk
  • Best results when combined with integration therapy

Stimulants (Cocaine, Methamphetamine, Crack)

40-60%Success rate at 12 months

Stimulant addiction presents unique challenges, but ibogaine helps:

  • Dopamine system repair reduces anhedonia and cravings
  • Psychological insight addresses compulsive use patterns
  • Variable success rates; may require repeated treatments
  • Most effective when addressing co-occurring trauma or depression

Polysubstance Use

Many patients use multiple substances. Ibogaine's multi-receptor action makes it uniquely suited for polysubstance addiction, addressing multiple dependencies simultaneously.

What to Expect: The Treatment Process

1. Medical Screening (Days 1-2)

Comprehensive cardiac assessment, bloodwork, psychological evaluation, and medication review to ensure safety.

2. Pre-Treatment Preparation (Days 3-5)

Tapering off substances if needed, preparing mentally, meeting the medical team, and establishing treatment intentions.

3. Ibogaine Session (Day 6, 24-36 hours)

Administration under continuous medical monitoring with cardiac telemetry. The experience unfolds in phases:

  • Hours 1-3: Onset, introspective visionary experience begins
  • Hours 4-12: Peak effects, deep psychological processing
  • Hours 12-24: Gradual return, withdrawal eliminated
  • Hours 24-36: Rest and recovery under observation

4. Recovery & Integration (Days 7-10)

Physical rest, psychological integration sessions, preparation for aftercare, and developing relapse prevention strategies.

5. Aftercare (Months 1-12+)

Ongoing therapy, support groups, lifestyle changes, and accountability structures are critical for long-term success.

Learn More

Read our detailed guide: What to Expect During Ibogaine Treatment

Curious about the science? Explore how ibogaine works to reset addiction pathways

Research Evidence

Brown et al. (2017) — Observational study of 88 opioid-dependent patients: 80% reported elimination of withdrawal symptoms within 24 hours; 50% remained abstinent at 12 months.

Noller et al. (2018) — Retrospective analysis of 30 patients: significant reductions in opioid withdrawal scores and cravings at 1-month follow-up.

Davis et al. (2017) — Survey of 88 individuals who self-administered ibogaine: 80% reported cessation of opioid use.

Mash et al. (2018) — Phase I/II trials demonstrating safety and efficacy for opioid detoxification with proper cardiac screening.

→ Explore Full Research Database

Why It Works When Others Fail

-Addresses the root cause: Repairs neurological damage rather than managing symptoms

-Eliminates barriers: No painful withdrawal, no daily dosing, no years of treatment

-Holistic healing: Combines neurochemical reset with psychological transformation

-Lasting change: Creates neuroplasticity window for building new, healthy patterns

Ready to Take the Next Step?

Explore your options, understand safety protocols, and connect with a trusted clinic.

Total Alkaloid (TA) Extract vs Ibogaine HCL

Virtually every ibogaine clinic in the world uses ibogaine hydrochloride (HCL) — a single isolated alkaloid that is typically semi-synthesized from Voacanga africana, a completely different African plant. This process extracts just 1 of the 12+ alkaloids found in the original iboga plant.

A growing number of clinics now offer Total Alkaloid (TA) extract derived directly from genuine Tabernanthe iboga root bark. TA preserves all 12+ naturally occurring alkaloids — ibogaine, noribogaine, tabernanthine, ibogamine, voacangine, coronaridine, and others — working synergistically for potentially superior therapeutic outcomes.